期刊文献+

白念珠菌ERG11基因启动子部分序列分析 被引量:2

Analysis on Partial Sequence of ERG11 Promoter Region of Candida albicans
原文传递
导出
摘要 目的探讨白念珠菌菌丝相与酵母相ERG11基因启动子部分(-440~-1)碱基序列的差异以及ERG11基因启动子突变与白念珠菌对氟康唑敏感性的关系。方法分别提取从同一亲本来源、对氟康唑敏感性不同的白念珠菌菌丝相与酵母相基因组DNA,根据ERG11基因启动子序列及其编码序列设计一对引物,对ERG11基因上游启动子部分碱基序列(-503~53)进行PCR扩增,经PCR产物直接测序比较白念珠菌菌丝相与酵母相ERG11基因启动子序列(-440~-1)的差异以及对氟康唑敏感性不同的白念珠菌ERG11基因启动子序列的差异。结果白念珠菌菌丝相与酵母相ERG11启动子序列未发现差异。氟康唑敏感株白念珠菌ERG11基因启动子的-365,-353,-328,-310,-308,-299,-295,-293,-292,290,-289位点为杂合状态,且在-284位点有一等位基因发生单碱基缺失(-284delT);而在白念珠菌氟康唑剂量依赖性敏感和耐药株上述杂合现象消失。结论白念珠菌菌丝相与酵母相ERG11基因启动子-440~-1区碱基序列无差异;ERG11基因启动子突变可能与白念珠菌对氟康唑耐药有关。 Objectives To compare the difference of ERG11 partial promoter sequence(-440 ~ -1)between yeast-form and hypha-form of Candida albicans, and the relation between the mutation of ERG11 promoter and the susceptibility of C. albicans to fluconazole. Methods Yeast-form and hypha-form of C. albicans genome DNA were extracted from 4 substrains C. albicans, which were isolated from a single HIV-sero-positive patient. Partial ERG11 promoters of yeast-form and hypha-form of these 4 substrains were amplified by polymerase chain reaction (PCR) and the PCR products were sequenced. Results There was no sequence difference between the yeast-form and the hypha-form of C. albicans in this region. Heterogeneities at position -365, -353, -328, -310, -308, -299, -295, -293, -292, 290, -289 and a single base deletion (-284 delT) were found on one allele of ERG11 promoter region of fluconazole-susceptible substrains. No heterogeneities were observed in dose-dependent fluconazole-susceptible and fluconazole-resistant substrains. Conclusions There is no difference of ERG11 partial promoter sequence between the yeast-form and the hypha-form C. albicans. The mutation of ERG11 promoter may be associated with the resistance of C. albicans to fluconazole.
作者 乔建军 张宏
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2005年第3期160-162,共3页 Chinese Journal of Dermatology
基金 国家自然科学基金资助项目(30070690)
关键词 ERG 白念珠菌 基因启动子 氟康唑 菌丝相 杂合 碱基序列 酵母 PCR产物 序列分析 Yeast-form Hyphae Candida albicans Promoter regions(Genetics) DNA mutational analysis Fluconazole
  • 相关文献

参考文献7

  • 1White TC, Pfaller MA, Rinaldi MG, et al. Stable azole drug resistance associated with a substrain of Candida albicans from an HIVinfected patient. Oral Dis, 1997, 3 (Suppl 1 ): 102-109.
  • 2Redding S, Smith J, Farinacci G, et al. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis, 1994, 18: 240-242.
  • 3石婧,张宏.白念珠菌菌丝相和酵母相ERG11基因部分序列差异性的探讨[J].中华皮肤科杂志,2004,37(8):472-474. 被引量:11
  • 4Choi W,Yoo YJ,Kim M,et al.Identification of proteins highly ex-pressed in the hypha of Candida albicans by two-dimensional electrophoresis.Yeast,2003,20:1053-1060.
  • 5李晋波,刘维达.特比萘芬对白念珠菌酵母相和菌丝相抗菌活性的比较[J].中华皮肤科杂志,2000,33(1):53-54. 被引量:21
  • 6White TC. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob Agents Chemother, 1997, 41: 1482-1487.
  • 7White TC. The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14alpha demethylase in Candida albicans. Antimicrob Agents Chemother, 1997, 41: 1488-1494.

二级参考文献10

  • 1White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev, 1998, 11: 382-402.
  • 2White TC. The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14 alpha demethylase in Candida albicans. Antimicrob Agents Chemother, 1997, 41: 1488-1494.
  • 3Redding S, Smith J, Farinacci G, et al. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis, 1994, 18: 240-242.
  • 4White TC, Pfaller MA, Rinaldi MG, et al. Stable azole drug resistance associated with a substrain of Candida albicans from an HIVinfected patient. Oral Dis, 1997, 3 Suppl 1: S102-109.
  • 5Ponton J, Jones JM. Analysis of cell wall extracts of Candida albicans by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blot techniques. Infect Immun, 1986, 53: 565-572.
  • 6Liu H. Transcriptional control of dimorphism in Candida albicans.Curr Opin Microbiol, 2001, 4: 728-735. [9]Schaude M, Ackerbauer H, Mieth H. Inhibitory effect of antifungal agents on germ tube formation in Candida albicans. Mykosen, 1987,30: 281-287.
  • 7Schaude M,Ackerbauer H,lnhibitory effect of antifungal agents on germ tube formation in Candida albicans.Mykosen, 1987,30:281-287.
  • 8郭宁如,现代真菌病诊断治疗学,1997年,51页
  • 9王文莉,李若瑜,王端礼,万哲,王晓红,李世荫,朱立煌.念珠菌对唑类药物耐药机理的探讨[J].中华皮肤科杂志,1997,30(5):306-309. 被引量:16
  • 10牛云彤,李少平.白念珠菌毒力因子研究进展[J].中国微生态学杂志,2000,12(1):60-61. 被引量:6

共引文献27

同被引文献26

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部